Exelixis
EXEL
#1569
Rank
ยฃ10.56 B
Marketcap
ยฃ42.03
Share price
0.79%
Change (1 day)
26.50%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company